Inhibitory effect of MK-801 on amantadine-induced dopamine release in the rat striatum

Brain Research Bulletin

Volumn 41, Issue 6, 1996, Pages 363-367

  Takahashi, Tetsuya ^a   Yamashita, Hiroshi ^a   Zhang, Y Xiang ^a   Nakamura, Shigenobu ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Amantadine; Dopamine; Glutamate; Microdialysis; Striatum

Indexed keywords

AMANTADINE; DIZOCILPINE; DOPAMINE; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG INHIBITION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION;

AMANTADINE; ANIMALS; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, WISTAR;

EID: 0030479727     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00211-0     Document Type: Article

References (30)

1. Baidessarini, R. J.; Lipinski, J. F.; Chace, K. Y. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat. Biochem. Pharmacol. 21:77-87; 1972.
2. 3H]dopamine from striatal slices. J. Pharmacol. Exp. Ther. 257:262-270; 1991.
3. Bustos, G.; Abarca, J.; Forray, M. I.; Gysling, K.; Bradberry, C. W.; Roth, R. H. Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: In vivo microdialysis studies. Brain Res. 585:105-115; 1992.
4. Costall, B.; Naylor, R. J. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan). Psychopharmacologia 43:53-61; 1975.
5. 2+ activity and of cyclic GMP level in a neuronal cell line. Eur. J. Pharmacol. 172:199-203; 1989.
6. Fletcher, E. A.; Redfern, P. H. The effect of amantadine on the uptake of dopamine and noradrenaline by rat brain homogenates. J. Pharm. Pharmacol. 22:957-959; 1970.
7. Gandolfi, O.; Rimondini, R.; Dall'Olio, R. The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms. Neuropharmacology 31:1111-1114; 1992.
8. Godukhin, O. V.; Zharikova, A. D.; Budantsev, A. Y. Role of presynaptic dopamine receptors in regulation of the glutamatergic neurotransmission in rat neostriatum. Neuroscience 12:377-383; 1984.
9. 3-dopamine in rat brain slices. Eur. J. Pharmacol. 20:156-160; 1972.
10. Herdon, H.; Nahorski, S. R. Investigation of the roles of dihydropyridine and conotoxin-sensitive calcium channels in mediating depolarization-evoked endogenous dopamine release from striatal slices. Naunyn Schmiedebergs Arch. Pharmacol. 340:36-40; 1989.
11. Kashihara, K.; Hamamura, T.; Okumura, K.; Otsuki, S. Effect of MK-801 on endogeous dopamine release in vivo. Brain Res. 528:80-82; 1990.
12. Kiss, J. P.; Tóth, E.; Lajtha, A.; Vizi, E. S. NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study. Brain Res. 641:145-148; 1994.
13. Kornhuber, J.; Bormann, J.; Hübers, M.; Rusche, K.; Riederer, P. Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: A human postmortem brain study. Eur. J. Pharmacol. 206:297-300; 1991.
14. Kornhuber, J.; Quack, G.; Danysz, W.; Jellinger, K.; Danielczyk, W.; Gsell, W.; Riederer, P. Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology 34:713-721; 1995.
15. Krebs, M. O.; Desce, J. M.; Kernel, M. L.; Gauchy, C.; Godeheu, G.; Cheramy, A.; Glowinski, J. Glutamatergic control of dopamine release in the rat striatum: Evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:81-85; 1991.
16. Llinas, R.; Sugimori, M.; Lin, J. W.; Cherksey, B. Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel-web spider poison. Proc. Natl. Acad. Sci. USA 86:1689-1693; 1989.
17. 3H] dopamine in the striatum of the conscious rat: in vivo perfusion and release of neuroactive substances. In: Bayon, A.; Drucker-Colin, R., eds. Methods and strategies. New York: Academic Press; 1985.
18. Menon, M. K.; Llark, W. G. Pharmacological evidence for the involement of GABAergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-amino-adamantane (D-145). Neuropharmacology 17:1049-1052; 1978.
19. Miller, D. W.; Abercrombie, E. D. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res. Bull. 40:57-62; 1996.
20. Morari, M.; O'Connor, W. T.; Ungerstedt, U.; Fuxe, K. N-Methyl-D-aspartatic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study. J. Neurochem. 60:1884-1893; 1993.
21. Rao, T. S.; Kim, H. S.; Lehmann, J.; Martin, L. L.; Wood, P. L. Interaction of phencyclidine receptor agonist MK-801 with dopaminergic system: Regional studies in the rat. J. Neurochem. 54:1157-1162; 1990.
22. 3H] dopamine release from rat striatum: an in vitro model for glutamate actions. J. Neurochem. 32:1539-1545; 1979.
23. Sandor, N. T.; Brassai, A.; Puskas, A.; Lendvai, B. Role of nitric oxide in modulating neurotransmitter release from rat striatum. Brain Res. Bull. 36:483-486; 1995.
24. Schwab, R. S.; England, A. C.; Poskanzer, D. C.; Young, R. R. Amantadine in the treatment of Parkinson's disease. JAMA 208:1168-1170; 1969.
25. Silverstein, F. S.; Naik, B. Effect of depolarization on striatal amino acid efflux in perinatal rats: An in vivo microdialysis study. Neurosci. Lett. 128:133-136; 1991.
26. Strömberg, U.; Svensson, T. H.; Waldeck, B. On the mode of action of amantadine. J. Pharm. Pharmacol. 22:959-961; 1970.
27. Vernier, V. G.; Harmon, J. B.; Stump, J. M.; Lynes, T. E.; Marvel, J. P.; Smith, D. H. The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol. Appl. Pharmacol. 15:642-65; 1969.
28. 2+ store of nonmuscle cells? Proc. Natl. Acad. Sci. USA 85:1091-1095; 1988.
29. Warnick, J. E.; Maleque, M. A.; Bakry, N.; Eldefrawi, A. T.; Albuquerque, E. X. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane. Mol. Pharmacol. 22:82-93; 1982.
30. Whitton, P. S.; Biggs, C. S.; Pearce, B. R.; Fowler, L. J. Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci. Lett. 142:5-8; 1992.